Albert E Holler

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Health Information

Men Who Have Sex With Men

Magnetic Resonance

Cross Sectional

Top Venues

JCO precision oncology

Molecular cancer therapeutics

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Sean A Fletcher, Mufaddal M Mamawala, Albert E Holler, Yasin Bhanji, Katarzyna J Macura, Claire M de la Calle, Christian P Pavlovich
Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era. The Prostate (2024)
Sean A Fletcher, Mufaddal M Mamawala, Albert E Holler, Yasin Bhanji, Katarzyna J Macura, Claire M de la Calle, Christian P Pavlovich
Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era. The Prostate 84 (8) (2024)
Vismaya S Bachu, Heba Mahjoub, Albert E Holler, Tudor Crihalmeanu, Dheevena M Bachu, Varun Ayyaswami, Pearman D Parker, Arpan V Prabhu
Assessing COVID-19 Health Information on Google Using the Quality Evaluation Scoring Tool (QUEST): Cross-sectional and Readability Analysis. JMIR formative research 6 (2) (2022)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)
Sudan N Loganathan, Nan Tang, Albert E Holler, Nenghui Wang, Jialiang Wang
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors. Molecular cancer therapeutics 18 (5) (2019)